Human Genome Sciences, Inc.

Vascular endothelial growth factor 2

#2 | 2014-11-06

US20140328794A1

ALBUMIN FUSION PROTEINS

#3 | 2014-10-09 ✅ Patent 8,993,517 granted on 2015-03-31

US20140303077A1

Albumin fusion proteins

#4 | 2014-06-26

US20140179596A1

ALBUMIN FUSION PROTEINS

#5 | 2014-01-23

US20140024812A1

ENGINEERED INTRACELLULAR SIALYLATION PATHWAYS

#6 | 2013-11-21 ✅ Patent 8,784,809 granted on 2014-07-22

US20130309232A1

Vascular endothelial growth factor 2

#7 | 2013-10-10 ✅ Patent 8,946,156 granted on 2015-02-03

US20130266553A1

Albumin Fusion Proteins

#8 | 2013-08-15 ✅ Patent 8,937,169 granted on 2015-01-20

US20130210149A1

Human G-protein chemokine receptor HSATU68

#9 | 2013-08-08

US20130203164A1

Human Secreted Proteins

#10 | 2013-06-13 ✅ Patent 8,513,189 granted on 2013-08-20

US20130150296A1

Albumin fusion proteins

#11 | 2013-05-02 ✅ Patent 8,969,538 granted on 2015-03-03

US20130108606A1

Albumin fusion proteins

#12 | 2012-08-23

US20120213777A1

VASCULAR ENDOTHELIAL GROWTH FACTOR 2

#13 | 2012-05-17

US20120122762A1

186 Human Secreted Proteins

#14 | 2012-05-17 ✅ Patent 9,187,548 granted on 2015-11-17

US20120121606A1

Antibodies that immunospecifically bind to B lymphocyte stimulator protein

#15 | 2012-03-08

US20120058119A1

HUMAN TUMOR NECROSIS FACTOR TR21 AND METHODS BASED THEREON

#16 | 2012-02-23 ✅ Patent 8,252,739 granted on 2012-08-28

US20120046221A1

Albumin fusion proteins

#17 | 2012-02-23

US20120045432A9

B LYMPHOCYTE STIMULATOR ASSAYS

#18 | 2012-02-16 ✅ Patent 8,231,873 granted on 2012-07-31

US20120039890A9

Methods of treatment using antibodies to Neutrokine-alpha

#19 | 2012-02-07 ✅ Patent 8,110,659 granted on 2012-02-07

US8718737

Human tumor necrosis factor receptor-like genes

#20 | 2012-01-26

US20120022006A1

B-LYMPHOCYTE STIMULATOR BINDING POLYPEPTIDES AND METHODS BASED THEREON

#21 | 2012-01-19

US20120016107A1

GROWTH FACTOR HTTER36

#22 | 2012-01-19

US20120014950A1

Antibodies That Specifically Bind to DR3

#23 | 2011-12-22

US20110311548A1

USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO TREAT ASTHMA AND OTHER ALLERGIC AND INFLAMMATORY CONDITIONS OF THE RESPIRATORY SYSTEM

#24 | 2011-12-06 ✅ Patent 8,071,092 granted on 2011-12-06

US9589288

Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha

#25 | 2011-12-01

US20110293610A1

ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN

#26 | 2011-10-20

US20110256145A1

Connective Tissue Growth Factor-3 (CTGF-3)

#27 | 2011-09-22 ✅ Patent 8,546,105 granted on 2013-10-01

US20110229931A1

Engineering intracellular sialylation pathways

#28 | 2011-09-22 ✅ Patent 8,206,708 granted on 2012-06-26

US20110229466A1

Vascular endothelial growth factor 2

#29 | 2011-09-15 ✅ Patent 8,268,979 granted on 2012-09-18

US20110224415A1

Human MutY

#30 | 2011-09-15

US20110223178A1

Antibodies That Specifically Bind to Chemokine Beta-4

#31 | 2011-08-23 ✅ Patent 8,003,386 granted on 2011-08-23

US9006352

Tumor necrosis factor receptors 6α and 6β

#32 | 2011-08-18

US20110201030A1

Human G-Protein Chemokine Receptor (CCR5) HDGNR10

#33 | 2011-08-04

US20110190223A1

HEMCM42 NUCLEIC ACIDS

#34 | 2011-08-04

US20110189197A1

Antibodies Against Protective Antigen

#35 | 2011-07-07

US20110165160A1

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

#36 | 2011-06-23

US20110151473A1

Polynucleotides and Polypeptides Encoding Receptors

#37 | 2011-06-21 ✅ Patent 7,964,190 granted on 2011-06-21

US10375680

Methods and compositions for decreasing T-cell activity

#38 | 2011-06-09

US20110135639A1

B LYMPHOCYTE STIMULATOR ASSAYS

#39 | 2011-05-19

US20110117093A1

ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN

#40 | 2011-05-12

US20110112177A1

Human G-Protein Coupled Receptor (HETGQ23)

#41 | 2011-05-05 ✅ Patent 7,968,689 granted on 2011-06-28

US20110105726A1

Antibodies to HSDEK49 polypeptides

#42 | 2011-04-07

US20110081360A1

Human G-Protein Chemokine Receptor (CCR5) HDGNR10

#43 | 2011-03-15 ✅ Patent 7,906,119 granted on 2011-03-15

US12421139

Antibodies against protective antigen

#44 | 2011-03-03

US20110052590A1

NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF

#45 | 2011-02-15 ✅ Patent 7,888,466 granted on 2011-02-15

US10411284

Human G-protein chemokine receptor HSATU68

#46 | 2011-02-10

US20110033470A1

Human G-Protein Coupled Receptor

#47 | 2011-01-27

US20110020380A1

Human Tumor Necrosis Factor TR18 and Methods Based Thereon

#48 | 2011-01-20

US20110014190A1

USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE

#49 | 2011-01-13 ✅ Patent 8,071,539 granted on 2011-12-06

US20110009312A1

Albumin fusion proteins

#50 | 2011-01-06 ✅ Patent 8,093,363 granted on 2012-01-10

US20110003399A1

Tumor necrosis factor-gamma

#51 | 2011-01-06 ✅ Patent 7,932,361 granted on 2011-04-26

US20110003383A1

Antibodies to HT5GJ57

#52 | 2011-01-06 ✅ Patent 8,287,859 granted on 2012-10-16

US20110002888A1

Methods of reducing toxicity and effects of cocaine by administering a butyrylcholinesterase (BChE)-albumin fusion protein

#53 | 2010-12-30

US20100330073A1

METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA

#54 | 2010-11-23 ✅ Patent 7,838,636 granted on 2010-11-23

US11760578

Antibodies to HWHGU54 polypeptides

#55 | 2010-11-11

US20100285449A1

Human G-Protein Chemokine Receptor (CCR5) HDGNR10

#56 | 2010-10-21 ✅ Patent 8,105,589 granted on 2012-01-31

US20100266533A1

Use of DR3 antibodies in the treatment of inflammatory disease

#57 | 2010-10-14 ✅ Patent 8,211,649 granted on 2012-07-03

US20100261207A9

Methods of diagnosing and prognosing hodgkin's lymphoma

#58 | 2010-10-14

US20100261194A1

NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF

#59 | 2010-10-07 ✅ Patent 8,410,248 granted on 2013-04-02

US20100255574A1

HWBAO62 polypeptides

#60 | 2010-09-28 ✅ Patent 7,803,615 granted on 2010-09-28

US9042583

Death domain containing receptor 5

#61 | 2010-09-23

US20100240875A1

Antibodies That Specifically Bind to Reg IV

#62 | 2010-09-23

US20100239564A1

NOVEL HUMAN GROWTH FACTORS

#63 | 2010-09-02 ✅ Patent 8,168,205 granted on 2012-05-01

US20100221287A1

polypeptides

#64 | 2010-08-05

US20100196410A1

Streptococcus pneumoniae Antigens and Vaccines

#65 | 2010-08-05 ✅ Patent 7,994,284 granted on 2011-08-09

US20100196383A1

Connective tissue growth factor (CTGF-3) polypeptides

#66 | 2010-08-05

US20100196360A9

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

#67 | 2010-06-10 ✅ Patent 8,062,906 granted on 2011-11-22

US20100144058A1

B-lymphocyte stimulator binding polypeptides and methods based thereon

#68 | 2010-06-10

US20100143360A1

HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 2

#69 | 2010-06-10 ✅ Patent 8,133,734 granted on 2012-03-13

US20100143246A1

Kit comprising an antibody to interleukin 17 receptor-like protein

#70 | 2010-05-06

US20100111953A1

ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR

#71 | 2010-04-15 ✅ Patent 8,143,026 granted on 2012-03-27

US20100093627A1

Albumin fusion proteins

#72 | 2010-02-18

US20100041136A1

Connective Tissue Growth Factor-2

#73 | 2010-02-18

US20100040624A1

Human Tumor Necrosis Factor TR21 and Methods Based Thereon

#74 | 2010-01-07 ✅ Patent 8,101,181 granted on 2012-01-24

US20100003259A1

Antibodies that immunospecifically bind to B lymphocyte stimulator protein

#75 | 2009-12-17

US20090311263A1

HUMAN VASCULAR IBP-LIKE GROWTH FACTOR

#76 | 2009-12-17 ✅ Patent 8,372,948 granted on 2013-02-12

US20090311256A1

12 human secreted proteins

#77 | 2009-12-10

US20090305991A1

33 Human Secreted Proteins

#78 | 2009-10-15 ✅ Patent 7,816,091 granted on 2010-10-19

US20090258357A1

Method of identifying a binding partner to a cytokine receptor common gamma chain like polypeptide

#79 | 2009-10-13 ✅ Patent 7,601,351 granted on 2009-10-13

US10602727

Antibodies against protective antigen

#80 | 2009-10-06 ✅ Patent 7,597,886 granted on 2009-10-06

US9899059

Tumor necrosis factor-gamma

#81 | 2009-10-01

US20090247482A1

50 Human Secreted Proteins

#82 | 2009-10-01

US20090246202A1

Human Endokine Alpha and Methods of Use

#83 | 2009-09-10 ✅ Patent 7,776,565 granted on 2010-08-17

US20090226968A1

Engineering intracellular sialylation pathways

#84 | 2009-09-10 ✅ Patent 7,709,218 granted on 2010-05-04

US20090226456A1

Tumor necrosis factor receptors 6α and 6β

#85 | 2009-09-10

US20090226429A1

Antibodies That Immunospecifically Bind to TRAIL Receptors

#86 | 2009-09-10 ✅ Patent 7,862,818 granted on 2011-01-04

US20090226416A1

Method of inhibiting human G-protein chemokine receptor (CCR5) HDGNR10

#87 | 2009-09-03

US20090221008A1

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

#88 | 2009-08-20 ✅ Patent 8,017,349 granted on 2011-09-13

US20090208974A1

Human neuronal attachment factor-1

#89 | 2009-08-20

US20090208969A1

Polynucleotides and Polypeptides Encoding Receptors

#90 | 2009-08-06

US20090197278A9

Antibodies to hADA2

#91 | 2009-07-30

US20090192088A1

Vascular Endothelial Growth Factor 2

#92 | 2009-07-02 ✅ Patent 8,303,951 granted on 2012-11-06

US20090169565A1

Neutrokine-alpha antibodies and methods of use thereof

#93 | 2009-06-11 ✅ Patent 7,906,634 granted on 2011-03-15

US20090148900A1

HEMCM42 nucleic acids

#94 | 2009-06-11 ✅ Patent 9,168,286 granted on 2015-10-27

US20090148462A1

Methods and compositions for use in treatment of patients with autoantibody positive disease

#95 | 2009-06-04 ✅ Patent 8,518,389 granted on 2013-08-27

US20090142353A1

Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides

#96 | 2009-06-04

US20090142329A1

Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4

#97 | 2009-05-21 ✅ Patent 7,910,321 granted on 2011-03-22

US20090131319A1

Methods of determining the level of human tumor necrosis factor receptor-like 2

#98 | 2009-05-07

US20090117043A1

Antibodies That Specifically Bind to Neurokinin B

#99 | 2009-04-23

US20090104622A1

Extracellular/Epidermal Growth Factor Like Protein

#100 | 2009-04-23

US20090104619A1